Analystreport

Unity Biotechnology, Inc. (NASDAQ: UBX) was upgraded by analysts at Roth Capital from a "neutral" rating to a "buy" rating.

Unity Biotechnology, Inc.  (UBX) 
Last unity biotechnology, inc. earnings: 3/11 04:05 pm Check Earnings Report